New
HealthMore in Health→
FDA Clears First Wearable That Tracks Ketones and Glucose Together
Key Takeaways
- The FDA authorized Abbott’s Libre Duo 10 Day for continuous ketone and glucose monitoring.
- The device is intended to warn earlier when ketone levels rise toward diabetic ketoacidosis risk.
- It is authorized for people with diabetes ages 2 and older and sends alerts through a smartphone app.
DE
DT Editorial Team··via medicalxpress.com
